A San Francisco Bay Area professional, Anna Beryozkina, PharmD, engages with a biotechnology corporation as an associate clinical scientist to develop effective strategies of molecule indication assignment. Part of the Clinical Science Team, Dr. Anna Beryozkina effectively leads cross-functional teams and has authored clinical trial protocols with support.

An alumna of McGill University with a BA in psychology and philosophy, Dr. Beryozkina received her PharmD from the Massachusetts College of Pharmacy and Health Sciences. Her experience includes providing counseling on medications and fulfilling prescriptions within a pharmacy setting.

Undertaking an industry fellowship with a Swiss multinational health care company, Dr. Beryozkina generated reports based on her analysis of Phase I pharmacodynamic and pharmacokinetic data. Before assuming her current role, she functioned as a regulatory program manager, in which capacity she guided a team in completing a new U.S. drug application. Professionally active, she attends several scientific conferences on an annual basis.